Education
About Us
Working with TipRanks
Follow Us
Nectar Lifesciences Ltd. (IN:NECLIFE)
:NECLIFE
NECLIFE Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹24.90 - ₹56.39
Previous CloseN/A
Volume216.67K
Average Volume (3M)N/A
Market Cap
₹5.88B
Enterprise Value₹15.10B
Total Cash (Recent Filing)₹212.89M
Total Debt (Recent Filing)₹9.03B
Price to Earnings (P/E)34.6
Beta0.50
Next Earnings
May 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 11, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)0.76
Shares Outstanding224,260,970
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.31
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nectar Lifesciences Ltd. News
---
NECLIFE FAQ
What was Nectar Lifesciences Ltd.’s price range in the past 12 months?
Nectar Lifesciences Ltd. lowest stock price was ₹24.90 and its highest was ₹56.39 in the past 12 months.
What is Nectar Lifesciences Ltd.’s market cap?
Nectar Lifesciences Ltd.’s market cap is ₹5.88B.
When is Nectar Lifesciences Ltd.’s upcoming earnings report date?
Nectar Lifesciences Ltd.’s upcoming earnings report date is May 26, 2025 which is in 77 days.
How were Nectar Lifesciences Ltd.’s earnings last quarter?
Nectar Lifesciences Ltd. released its earnings results on Jan 31, 2025. The company reported ₹0.35 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.35.
Is Nectar Lifesciences Ltd. overvalued?
According to Wall Street analysts Nectar Lifesciences Ltd.’s price is currently Overvalued.
Does Nectar Lifesciences Ltd. pay dividends?
Nectar Lifesciences Ltd. pays a Annually dividend of ₹0.05 which represents an annual dividend yield of N/A. See more information on Nectar Lifesciences Ltd. dividends here
What is Nectar Lifesciences Ltd.’s EPS estimate?
Nectar Lifesciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nectar Lifesciences Ltd. have?
Nectar Lifesciences Ltd. has 224,260,970 shares outstanding.
What happened to Nectar Lifesciences Ltd.’s price movement after its last earnings report?
Nectar Lifesciences Ltd. reported an EPS of ₹0.35 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.995%.
Which hedge fund is a major shareholder of Nectar Lifesciences Ltd.?
Currently, no hedge funds are holding shares in IN:NECLIFE
---
Technical Analysis
Aurobindo Pharma Ltd
―
Divi's Laboratories Limited
―
Dr. Reddy's Laboratories Ltd.
―
Lupin Limited
―
Sun Pharmaceutical Industries Limited
―
---